|
|
regionalization
|
GO:0003002 |
337 |
0.325
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.324
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.318
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.299
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.284
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.238
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.226
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.224
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.224
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.222
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.203
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.195
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.187
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.183
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.183
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.181
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.176
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.176
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.175
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.171
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.171
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.160
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.158
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.148
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.148
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.147
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.144
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.141
|
|
|
|
negative regulation of bmp signaling pathway
|
GO:0030514 |
35 |
0.140
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.140
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.140
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.135
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.135
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.135
|
Human |
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.133
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.130
|
Human |
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.128
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.127
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.126
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.126
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.125
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.125
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.117
|
Human |
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.117
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.113
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.110
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.107
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.107
|
Mouse |
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.107
|
|
|
|
canonical wnt signaling pathway involved in regulation of cell proliferation
|
GO:0044340 |
3 |
0.106
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.104
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.104
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.101
|
|
|
|
non canonical wnt signaling pathway via jnk cascade
|
GO:0038031 |
3 |
0.098
|
Mouse |
|
|
skeletal system development
|
GO:0001501 |
356 |
0.096
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.096
|
|
|
|
ubiquitin dependent smad protein catabolic process
|
GO:0030579 |
2 |
0.096
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.095
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.094
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.093
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.093
|
Human |
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.093
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.092
|
Human |
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.092
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.091
|
|
|
|
positive regulation of lymphocyte anergy
|
GO:0002913 |
4 |
0.090
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.089
|
Human |
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.088
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.088
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.088
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.087
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.086
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.085
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.085
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.084
|
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
46 |
0.083
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.083
|
Human |
|
|
immune effector process
|
GO:0002252 |
321 |
0.082
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.081
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.080
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.079
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.079
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.079
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.079
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.078
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.078
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.077
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.076
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.076
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.075
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.075
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.075
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.074
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.074
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.074
|
|
|
|
establishment of tissue polarity
|
GO:0007164 |
28 |
0.073
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.073
|
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.073
|
|
|
|
wnt signaling pathway planar cell polarity pathway
|
GO:0060071 |
27 |
0.072
|
Mouse |
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.071
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.069
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.069
|
|
|
|
t cell anergy
|
GO:0002870 |
4 |
0.069
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.068
|
|
|
|
non canonical wnt signaling pathway via mapk cascade
|
GO:0038030 |
3 |
0.068
|
Mouse |
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.068
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.068
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.068
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.067
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.067
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.066
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.066
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.066
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.066
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.066
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.066
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.066
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.065
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.065
|
|
|
|
cell fate determination
|
GO:0001709 |
32 |
0.065
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.065
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.065
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.064
|
Human |
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.064
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.064
|
|
|
|
lymphocyte anergy
|
GO:0002249 |
4 |
0.063
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.063
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.063
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.063
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.063
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.063
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.063
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.063
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.062
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.061
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.061
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.060
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.060
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.060
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.060
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.060
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.059
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.059
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.059
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.059
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.058
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.058
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.058
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.058
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.058
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.058
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.057
|
|
|
|
salivary gland morphogenesis
|
GO:0007435 |
33 |
0.057
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.057
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.056
|
|
|
|
outflow tract morphogenesis
|
GO:0003151 |
53 |
0.056
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.055
|
|
|
|
cochlea development
|
GO:0090102 |
35 |
0.055
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.055
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.055
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.055
|
|
|
|
regulation of lymphocyte anergy
|
GO:0002911 |
4 |
0.055
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.054
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.054
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.054
|
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
37 |
0.054
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.054
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.053
|
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
65 |
0.053
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.053
|
|
|
|
exocrine system development
|
GO:0035272 |
45 |
0.053
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.053
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.053
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.052
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.052
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.052
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.052
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
40 |
0.052
|
|
|
|
regulation of t cell anergy
|
GO:0002667 |
4 |
0.052
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.052
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.052
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.051
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.051
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.051
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.051
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.051
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.051
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.051
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.051
|
Human |
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.051
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.051
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.051
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.050
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.050
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.050
|
Human |
|
|
segmentation
|
GO:0035282 |
93 |
0.050
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.050
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.050
|
|
|
|
positive regulation of t cell anergy
|
GO:0002669 |
4 |
0.049
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.049
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.049
|
|
|
|
cochlea morphogenesis
|
GO:0090103 |
22 |
0.049
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.049
|
Human |
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.048
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.048
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.048
|
|
|
|
actin filament bundle assembly
|
GO:0051017 |
40 |
0.048
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.048
|
|
|
|
regulation of actin filament bundle assembly
|
GO:0032231 |
18 |
0.048
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.048
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.048
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.048
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.047
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.047
|
Mouse |
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.047
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.047
|
|
|
|
regulation of jnk cascade
|
GO:0046328 |
62 |
0.046
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.046
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.046
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.045
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.045
|
|
|
|
negative regulation of lymphocyte proliferation
|
GO:0050672 |
45 |
0.045
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.045
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.045
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.045
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.045
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.045
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.044
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.044
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.044
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.044
|
Human |
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.044
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.043
|
|
|
|
vagus nerve development
|
GO:0021564 |
3 |
0.043
|
|
|
|
trachea cartilage morphogenesis
|
GO:0060535 |
4 |
0.043
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.043
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.043
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.043
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.042
|
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
68 |
0.042
|
|
|
|
cell cell signaling involved in cell fate commitment
|
GO:0045168 |
35 |
0.042
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.042
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.041
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.041
|
|
|
|
negative regulation of cardiac chamber morphogenesis
|
GO:1901220 |
2 |
0.041
|
|
|
|
ventricular septum development
|
GO:0003281 |
42 |
0.041
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.041
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.041
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.040
|
Human |
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.040
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.040
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.040
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.040
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.040
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.040
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.040
|
|
|
|
protein polyubiquitination
|
GO:0000209 |
33 |
0.040
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.040
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.040
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.039
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.039
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.039
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.039
|
|
|
|
regulation of asymmetric cell division
|
GO:0009786 |
4 |
0.039
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.039
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.039
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.039
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.038
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.038
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.038
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.038
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.038
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.038
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.038
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.038
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.038
|
Human Mouse |
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.038
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.038
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.037
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.037
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.037
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.037
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.037
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.037
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.037
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.037
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.036
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.036
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.036
|
|
|
|
positive regulation of muscle tissue development
|
GO:1901863 |
32 |
0.036
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.035
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.035
|
|
|
|
non canonical wnt signaling pathway
|
GO:0035567 |
33 |
0.035
|
Mouse |
|
|
regulation of protein targeting
|
GO:1903533 |
61 |
0.035
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.035
|
|
|
|
regulation of stress activated mapk cascade
|
GO:0032872 |
69 |
0.035
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.035
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.034
|
|
|
|
planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:0061347 |
2 |
0.034
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.034
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.034
|
Human Mouse |
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.034
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.034
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.034
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.034
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.034
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.034
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.034
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.033
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.033
|
|
|
|
dorsal ventral axon guidance
|
GO:0033563 |
3 |
0.033
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.033
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.033
|
|
|
|
defense response to virus
|
GO:0051607 |
68 |
0.033
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.033
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.033
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.032
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.032
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.032
|
Human |
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.032
|
|
|
|
mesonephric tubule morphogenesis
|
GO:0072171 |
63 |
0.032
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.032
|
|
|
|
mechanoreceptor differentiation
|
GO:0042490 |
67 |
0.032
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.032
|
|
|
|
negative regulation of t cell proliferation
|
GO:0042130 |
38 |
0.032
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.031
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.031
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.031
|
Human |
|
|
gliogenesis
|
GO:0042063 |
141 |
0.031
|
|
|
|
non canonical wnt signaling pathway involved in heart development
|
GO:0061341 |
3 |
0.031
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.031
|
|
|
|
t cell activation involved in immune response
|
GO:0002286 |
43 |
0.031
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.030
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.030
|
|
|
|
wnt signaling pathway involved in forebrain neuroblast division
|
GO:0021874 |
2 |
0.030
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.030
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.030
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.030
|
Human |
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.030
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.030
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.030
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.030
|
|
|
|
negative chemotaxis
|
GO:0050919 |
14 |
0.030
|
|
|
|
asymmetric neuroblast division
|
GO:0055059 |
1 |
0.030
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.030
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.030
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.030
|
|
|
|
schwann cell development
|
GO:0014044 |
22 |
0.030
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.029
|
|
|
|
ubiquitin dependent protein catabolic process via the multivesicular body sorting pathway
|
GO:0043162 |
3 |
0.029
|
|
|
|
wnt signaling pathway calcium modulating pathway
|
GO:0007223 |
2 |
0.029
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.029
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.029
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.029
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.029
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.029
|
|
|
|
uterus morphogenesis
|
GO:0061038 |
2 |
0.029
|
|
|
|
salivary gland development
|
GO:0007431 |
37 |
0.028
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.028
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.028
|
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.028
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.028
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.028
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.028
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.028
|
|
|
|
regulation of tight junction assembly
|
GO:2000810 |
2 |
0.028
|
|
|
|
regulation of alpha beta t cell activation
|
GO:0046634 |
53 |
0.028
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.028
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.028
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.028
|
|
|
|
mesoderm formation
|
GO:0001707 |
62 |
0.028
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.028
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.028
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.028
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.028
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.028
|
|
|
|
negative regulation of leukocyte proliferation
|
GO:0070664 |
46 |
0.028
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.027
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.027
|
|
|
|
regulation of establishment of planar polarity
|
GO:0090175 |
28 |
0.027
|
Mouse |
|
|
positive regulation of anagen
|
GO:0051885 |
1 |
0.027
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
63 |
0.027
|
|
|
|
positive regulation of neuron projection regeneration
|
GO:0070572 |
2 |
0.027
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.027
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.027
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.027
|
|
|
|
cell fate commitment involved in formation of primary germ layer
|
GO:0060795 |
26 |
0.027
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.027
|
|
|
|
positive regulation of epithelial cell proliferation involved in lung morphogenesis
|
GO:0060501 |
3 |
0.027
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.027
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.027
|
|
|
|
establishment of planar polarity of embryonic epithelium
|
GO:0042249 |
16 |
0.027
|
|
|
|
positive regulation of protein catabolic process
|
GO:0045732 |
60 |
0.027
|
Human |
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.027
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.026
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.026
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.026
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.026
|
|
|
|
mesonephric duct morphogenesis
|
GO:0072180 |
4 |
0.026
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.026
|
|
|
|
regulation of cell cell adhesion mediated by cadherin
|
GO:2000047 |
2 |
0.026
|
|
|
|
forebrain neuron differentiation
|
GO:0021879 |
52 |
0.026
|
|
|
|
planar cell polarity pathway involved in heart morphogenesis
|
GO:0061346 |
3 |
0.026
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.026
|
|
|
|
endoderm formation
|
GO:0001706 |
20 |
0.026
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.026
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.025
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.025
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.025
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.025
|
Human |
|
|
ventricular septum morphogenesis
|
GO:0060412 |
27 |
0.025
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.025
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.025
|
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
47 |
0.025
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.025
|
|
|
|
protein ubiquitination involved in ubiquitin dependent protein catabolic process
|
GO:0042787 |
25 |
0.025
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.025
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.025
|
|
|
|
regulation of protein modification by small protein conjugation or removal
|
GO:1903320 |
57 |
0.025
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.025
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.024
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.024
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.024
|
|
|
|
formation of organ boundary
|
GO:0010160 |
1 |
0.024
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.024
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.024
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.024
|
Human |
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.024
|
|
|
|
establishment or maintenance of apical basal cell polarity
|
GO:0035088 |
21 |
0.024
|
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.024
|
|
|
|
auditory receptor cell differentiation
|
GO:0042491 |
37 |
0.024
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.024
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.024
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.024
|
|
|
|
cerebral cortex radially oriented cell migration
|
GO:0021799 |
31 |
0.024
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.024
|
Human |
|
|
inner ear receptor cell differentiation
|
GO:0060113 |
61 |
0.024
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.024
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.024
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.024
|
|
|
|
cardiac cell fate specification
|
GO:0060912 |
2 |
0.024
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.024
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.024
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.024
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.024
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in myocardial precursor cell differentiation
|
GO:0003257 |
3 |
0.023
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.023
|
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
43 |
0.023
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.023
|
|
|
|
establishment of planar polarity
|
GO:0001736 |
28 |
0.023
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.023
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.023
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.023
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.023
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.023
|
Human |
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
73 |
0.023
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.023
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.023
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.022
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.022
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.022
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.022
|
|
|
|
schwann cell differentiation
|
GO:0014037 |
26 |
0.022
|
|
|
|
positive regulation of striated muscle tissue development
|
GO:0045844 |
31 |
0.022
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.022
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.022
|
|
|
|
negative regulation of transforming growth factor beta receptor signaling pathway
|
GO:0030512 |
26 |
0.022
|
|
|
|
cardiac septum morphogenesis
|
GO:0060411 |
46 |
0.022
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.022
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.022
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.022
|
|
|
|
neurotransmitter transport
|
GO:0006836 |
76 |
0.022
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.022
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.022
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.022
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.021
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.021
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.021
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.021
|
|
|
|
negative regulation of hormone metabolic process
|
GO:0032351 |
4 |
0.021
|
|
|
|
regulation of rho gtpase activity
|
GO:0032319 |
58 |
0.021
|
|
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
61 |
0.021
|
|
|
|
mammary gland epithelium development
|
GO:0061180 |
65 |
0.021
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.021
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.021
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.021
|
|
|
|
positive regulation of interleukin 8 secretion
|
GO:2000484 |
1 |
0.021
|
|
|
|
specification of organ identity
|
GO:0010092 |
30 |
0.021
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.021
|
|
|
|
establishment of planar polarity involved in neural tube closure
|
GO:0090177 |
15 |
0.021
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in heart development
|
GO:1901228 |
4 |
0.021
|
|
|
|
skin morphogenesis
|
GO:0043589 |
38 |
0.021
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.021
|
|
